{"title":"Liposomal Ingredients","description":"\u003cp\u003ePhospholipid-based delivery systems for enhanced performance and stability.\u003c\/p\u003e","products":[{"product_id":"liposomal-iron-b2b-ingredient","title":"Liposomal Iron - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003ePhospholipid-delivered iron concept for premium immediate-release formulations.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery iron concept for premium B2B formulations. Designed to investigate delivery and tolerability advantages while maintaining an immediate, non-modified-release profile.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Iron active in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Use the term \"liposomal iron\" only if characterized phospholipid vesicles and the association of iron with those vesicles are demonstrated. Otherwise use a technically accurate term such as phospholipid-delivered iron or phospholipid-coated microencapsulated iron. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506004889948,"sku":"NG-LIP-IRON","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_6e2ba483-5770-481b-a00c-300180c0c936.png?v=1785519777"},{"product_id":"liposomal-coenzyme-q10-b2b-ingredient","title":"Liposomal Coenzyme Q10 - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003ePhospholipid-delivered Coenzyme Q10 concept for improved formulation and dispersion.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery Coenzyme Q10 concept designed to address very poor water solubility, support dispersion, and enable premium oral formulations.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-02\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Coenzyme Q10 in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Core product. Demonstrate formulation-specific dispersion, active association, oxidative stability, and performance versus conventional Coenzyme Q10. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506008428892,"sku":"NG-LIP-COQ10","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_30583547-ffdc-4e85-9624-14908f035574.png?v=1785519780"},{"product_id":"liposomal-vitamin-c-b2b-ingredient","title":"Liposomal Vitamin C - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal vitamin C concept for immediate-release premium formulations.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery vitamin C concept for premium oral formulations, with product-specific characterization and stability evidence.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-03\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Vitamin C in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Core but commercially crowded category. Establish a product-specific evidence package rather than relying on generic liposomal claims. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506010755420,"sku":"NG-LIP-VITC","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_42c86582-f3c0-4154-89a7-13eda756a740.png?v=1785519783"},{"product_id":"liposomal-glutathione-b2b-ingredient","title":"Liposomal Glutathione - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003ePhospholipid-delivered glutathione concept focused on stability and premium oral delivery.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery reduced glutathione concept intended to protect the active from degradation and support a premium oral-delivery proposition.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-04\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Reduced glutathione in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Strong secondary product. Characterize oxidation control, free versus associated glutathione, reconstitution behaviour where relevant, and shelf-life stability. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506022224220,"sku":"NG-LIP-GSH","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_742141c2-2285-40d1-aff7-7e6844248a96.png?v=1785519785"},{"product_id":"liposomal-curcumin-b2b-ingredient","title":"Liposomal Curcumin - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal curcumin concept focused on dispersion and delivery limitations.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery curcumin concept designed to address poor aqueous solubility and low conventional oral exposure.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-05\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Curcumin in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Selective-development product. Benchmark performance against other delivery technologies and substantiate any formulation-performance advantage with product-specific data. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506027270492,"sku":"NG-LIP-CUR","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_43f9e620-9407-45d4-8433-7b396827f9a6.png?v=1785519788"},{"product_id":"liposomal-vitamin-d3-b2b-ingredient","title":"Liposomal Vitamin D3 - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal vitamin D3 concept for low-dose liquid or dry formulations.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery vitamin D3 concept for liquid or dry formats, designed for low-dose distribution and formulation flexibility.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-06\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Vitamin D3 in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Secondary product. Confirm potency uniformity, protection during shelf life, supplied-state particle size, and reconstituted particle size where a dry format is developed. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506031006044,"sku":"NG-LIP-VITD3","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_624aab41-3cb2-493d-83c0-e9d9f563431a.png?v=1785519795"},{"product_id":"liposomal-vitamin-k2-mk-7-b2b-ingredient","title":"Liposomal Vitamin K2 MK-7 - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal vitamin K2 MK-7 concept for low-dose distribution and dispersion.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery vitamin K2 MK-7 concept designed for low-dose uniformity, dispersion, and formulation handling.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-07\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Vitamin K2 MK-7 in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Secondary product added to the initial commercial range by NexaGens. Confirm potency, cis\/trans profile where applicable, low-dose uniformity, light\/oxidative stability, and phospholipid association. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506032808284,"sku":"NG-LIP-VITK2","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_38d43fa2-8a01-43f2-aee2-3da6091ff964.png?v=1785519798"}],"url":"https:\/\/nexagens.com\/collections\/liposomal-ingredients.oembed","provider":"Nexagens","version":"1.0","type":"link"}